While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee ...

PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.

CTX-471 is under clinical development by Compass Therapeutics and currently in Phase I for Head And Neck Cancer.

The Jimmy Carter drug introduced the world to cancer immunotherapy, a treatment that differs from chemotherapy. Carter was ...

GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC ...

Obsessed with chai Or Coffee Well its your day to be happy Recent research suggests that this daily ritual might be lowering ...

Rahway, NJ, USA) anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in first line recurrent/metastatic head ... this novel IO combination in head and neck squamous cell cancers with PD-L1 CPS <1.

In the latest statistical salvo of an ongoing debate, people who consumed more than four cups of caffeinated coffee daily had a lower risk of head and neck cancer (HNC), according to a meta-analysis ...

In an analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancer, including cancers of the mouth and throat.